Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 13 Carcinoma, Non-Small-Cell Lung 7 Breast Neoplasms 5 Prostatic Neoplasms 4 Neoplasm Metastasis 3 Melanoma 3 Carcinoma, Hepatocellular 3 Urinary Bladder Neoplasms 2 Sarcoma 2 Pancreatic Neoplasms 2 Neoplastic Cells, Circulating 2 Multiple Myeloma 2 Lung Neoplasms 2 Liver Neoplasms 2 Glioblastoma 2 Fibrosis 2 Colorectal Neoplasms 2 Cachexia 2 Vascular Malformations 1 Uterine Cervical Neoplasms 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Renal Insufficiency, Chronic 1 Recurrence 1 Pneumonia 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Osteosarcoma 1 Obesity 1

Interventions

Cyclophosphamide 12 aldesleukin 9 fludarabine 8 fludarabine phosphate 7 pembrolizumab 6 Ipilimumab 5 Interleukin-2 5 Nivolumab 4 dabrafenib 2 Vemurafenib 2 Biopsy 2 Aminolevulinic Acid 2 varlilumab 1 trametinib 1 tilsotolimod 1 spartalizumab 1 sotigalimab 1 sonidegib 1 smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic 1 glembatumumab vedotin 1 eprenetapopt 1 epacadostat 1 encorafenib 1 cemiplimab 1 cabozantinib 1 binimetinib 1 bempegaldesleukin 1 abobotulinumtoxinA 1 X-Rays 1 Tranexamic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Skin Neoplasms × Blood Specimen Collection × Clear all

NCT03603587 2020-03-05

BACCHUS

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Terminated

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡